Clinical Trial: In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07715630) titled 'In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma' on July 14.

Brief Summary: This study is an investigator-initiated, single-center, single-arm clinical study with a target population of patients with relapsed or refractory multiple myeloma.

It is an early exploratory clinical study evaluating the safety, tolerability, and preliminary efficacy of PICX Injection, an in vivo prepared CAR-T cell therapy, in the treatment of relapsed or refractory multiple myeloma.

Study Start Date: July 31

Study Type: INTERVENTIONAL

Condition: Relapsed or Refractory Multiple Myeloma (RRMM)

Intervention: BIOLOGICAL: Invivo CAR-T

Patients were...